Lack of evidence for claims of farmers in south-eastern Germany regarding adverse reactions ascribed to BTV-8 vaccines;Mangelnde Beweise für die von Landwirten im Südosten Deutschlands geltend gemachten Schäden der Impfung gegen die Blauzungenkrankheit

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 124, Issue 7-8, 2011, Pages 282-287

  Probst, Carolina ^a   Gethmann, Jörn M ^a   Höreth Böntgen, Detlef ^a   Cussler, Klaus ^b   Conraths, Franz J ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Adverse reactions; Bluetongue virus; Serotype 8; Vaccination

Indexed keywords

BLUETONGUE VIRUS;

VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLUETONGUE; BLUETONGUE ORBIVIRUS; CATTLE; CATTLE DISEASE; DRUG SURVEILLANCE PROGRAM; GERMANY; IMMUNIZATION; QUESTIONNAIRE; STANDARD; STATISTICS;

ANIMALS; BLUETONGUE; BLUETONGUE VIRUS; CATTLE; CATTLE DISEASES; GERMANY; IMMUNIZATION; PHARMACOVIGILANCE; QUESTIONNAIRES; VIRAL VACCINES;

EID: 84555189566     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: 10.2376/0005-9366-124-282     Document Type: Article

References (16)

1. Bruckner L, Fricker R, Hug M, Hotz R, Muntwyler J, Iten C, Griot C (2009): Vaccination against Bluetongue. Safety and immune response in the field. Schweiz Arch Tierheilkd 151: 101-108.
2. Conraths FJ, Gethmann JM, Staubach C, Mettenleiter TC, Beer M, Hoffmann B (2009): Epidemiology of Bluetongue Virus Serotype 8, Germany. Emerg Infect Dis 15 (3): 433-435.
3. Cußler K, Hoffmann A, Nesseler A, Fröhlich T (2009): Auswertung der Nebenwirkungsmeldungen nach der Impfung gegen die Blauzungenkrankheit in Hessen für das Jahr 2008. Prakt Tierarzt 90: 142-150.
4. EMA (2010): Guidance notes on the use of VeDDRA terminology for reporting suspected adverse reactions in animals and humans, http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/10/WC500005087.pdf
5. EMA (2009): An overview of field safety data from the EU for Bluetongue virus vaccines serotype 8 emerging from the 2008 national vaccination campaigns. EMEA/CVMP/652019/2008, http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/12/WC500017480.pdf
6. EMA (2005): Guideline on EU veterinary suspected adverse reaction report form for veterinarians and health professionals, http://eudravigilance.ema.europa.eu/veterinary/089304en.pdf
7. EMA (2004): Guideline on harmonising the approach to causality assessment for adverse reactions to veterinary medicinal products, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004995.pdf
8. Eschbaumer M, Hoffmann B, König P, Teifke J, Gethmann J, Conraths FJ, Probst C, Mettenleiter TC, Beer M (2009): Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Vaccine 27: 4169-4175.
9. European Commission (2004): The Rules governing medicinal products in the European Union, Volume 9, Part II. 1. Pharmacovigilance of Veterinary Medicinal Products. http://ec.europa. eu/health/documents/eudralex/vol-9/index_en.htm
10. Gethmann J, Hüttner K, Heyne H, Probst C, Ziller M, Beer M, Hoffmann B, Mettenleiter TC, Conraths FJ (2009): Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. Vaccine 27: 4118-4126.
11. González JM, Figueras L, Ortega ME, Lozano M, Ruiz de Arcaute M, Royo R, Cebrián LM, Ferrer LM, Fariñas F, García de Jalón JA, De las Heras M (2010): Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines. Vet Rec 166: 757-758.
12. Hoffmann A, Cußler K (2009): Impfkampagne zur Bekämpfung der Blauzungenkrankheit: Erste Analyse und Bewertung der 2008 gemeldeten Impfreaktionen. DTBl 2: 166-168.
13. Hofmann MA, Renzullo S, Mader M, Chaignat V, Worwa G, Thuer B (2008): Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg Infect Dis 14: 1855-1861.
14. Müntener CR, Bruckner L, Stürer A, Althaus FR, Caduff-Janosa P (2010): Vigilance der Tierarzneimittel: Gemeldete unerwünschte Wirkungen im Jahr 2009. Schweiz Arch Tierheilkd 12: 575-583.
15. Schalm, OW, Noorlander DO (1957): Experiments and observations leading to development of the California mastitis test. J Am Vet Med Assoc 130: 199.
16. Tschuor A, Hässig M, Kaufmann T, Strabel D (2010): Abklärung von Aborten und anderen tiergesundheitlichen Problemen im Zusammenhang mit der Blauzungenvirus-Impfung, Schweiz Arch Tierheilkd 152: 501-506.